GlassScriptPhysician profile
Austin P Bell
NPI 1093008302
$25,500.48
in general payments reported to CMS, 2019-2025
26 companies · $13K in 2025
The $13K reported for 2025 was more than what 93% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,319 · 2020: $1,713 · 2021: $5,394 · 2022: $680 · 2023: $743 · 2024: $1,191 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,480 · Food and Beverage: $3,519 · Travel and Lodging: $2,308 · Entertainment: $62.38 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,480.00 |
| Food and Beverage | $3,518.67 |
| Travel and Lodging | $2,307.84 |
| Entertainment | $62.38 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $8,872.75 | 2023-2025 | Envista Mx60 Iol, Miebo, Vyzulta |
| Ivantis, INC | $7,800.31 | 2019-2021 | |
| Glaukos Corporation | $4,431.29 | 2019-2025 | Idose, Istent Infinite, Idosetr |
| Abbvie INC. | $1,121.38 | 2022-2025 | Lumigan, Alphagan P, Durysta |
| Alcon Vision LLC | $674.60 | 2019-2025 | Hydrus Microstent, Clareon, Rocklatan |
| Rxsight INC | $485.95 | 2021-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| The Cameron-Ehlen Group, INC. | $415.59 | 2019-2021 | |
| Allergan, INC. | $317.59 | 2021-2022 | |
| Ocular Therapeutix, INC. | $297.65 | 2023-2025 | Dextenza |
| Carl Zeiss Meditec USA, INC. | $292.59 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $208.48 | 2019-2021 | |
| Biotissue Holdings INC. | $143.01 | 2021-2025 | |
| Optos, INC. | $62.38 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec, INC. | $60.00 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $47.48 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $39.73 | 2025 | Tepezza |
| Kala Pharmaceuticals, INC. | $39.30 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $37.48 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $33.06 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $30.76 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $25.78 | 2019 | |
| Horizon Therapeutics Plc | $20.28 | 2021 | |
| Dompe US, INC. | $15.44 | 2019 | |
| Oyster Point Pharma, INC. | $14.96 | 2024 | Ryzumvi, Tyrvaya |
| New World Medical,INC. | $12.64 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.